QSAM Biosciences, Inc.
QSAM · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$484 | -$1,164 | -$1,238 | -$1,507 |
| Dep. & Amort. | $0 | $0 | $0 | $36 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $860 | $103 | $122 | $169 |
| Change in WC | -$731 | $314 | $66 | $206 |
| Other Non-Cash | -$805 | $304 | $245 | $655 |
| Operating Cash Flow | -$1,160 | -$443 | -$804 | -$440 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,100 | $500 | $60 | $254 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,100 | $500 | $343 | $1,067 |
| Financing Cash Flow | $2,100 | $500 | $343 | $1,067 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $940 | $57 | -$462 | $626 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $447 | $390 | $851 | $225 |
| End Cash | $1,386 | $447 | $390 | $851 |
| Free Cash Flow | -$1,160 | -$443 | -$804 | -$440 |